Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug-Receptor Interactions01:29

Drug-Receptor Interactions

7.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.3K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.7K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.7K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.7K
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

336
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
336
Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

3.6K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.6K
Drug Biotransformation: Overview01:28

Drug Biotransformation: Overview

2.4K
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Favorable response to surufatinib in a patient with necrolytic migratory erythema: A case report.

Open life sciences·2023
Same author

Angioplasty Guidewire-Assisted vs. Conventional Transseptal Puncture for Left Atrial Appendage Occlusion: a multicentre randomized controlled trial.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2023
Same author

Central vertical regulation and urban environment-biased technological progress: evidence from China.

Environmental science and pollution research international·2023
Same author

Smart Dual-Exsolved Self-Assembled Anode Enables Efficient and Robust Methane-Fueled Solid Oxide Fuel Cells.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2023
Same author

Ambient Îł-Rays-Mediated Noble-Metal Deposition on Defect-Rich Manganese Oxide for Glycerol-Assisted H<sub>2</sub> Evolution at Industrial-Level Current Density.

Angewandte Chemie (International ed. in English)·2023
Same author

The allometric relationship between carbon emission and economic development in Yangtze River Delta: fusion of multi-source remote sensing nighttime light data.

Environmental science and pollution research international·2023
Same journal

An optimized cascaded transformer with progressive attention for lung and colon cancer diagnosis from histopathological images.

Computational biology and chemistry·2026
Same journal

From cross cancer transcriptomics to therapeutics: WGX-50 target hub genes in breast cancer and non-small cell lung carcinoma.

Computational biology and chemistry·2026
Same journal

Blood-based biomarker discovery through integrative transcriptomic and miRNA network analyses in schizophrenia, major depressive disorder, and bipolar disorder.

Computational biology and chemistry·2026
Same journal

A SUZ12-marked epithelial dedifferentiation state with immune co-expression in pancreatic ductal adenocarcinoma.

Computational biology and chemistry·2026
Same journal

In silico evaluation of isochlorogenic acid as a potential AbPf2 inhibitor for managing Alternaria pathogenicity.

Computational biology and chemistry·2026
Same journal

Comparison of nanopore sequencing, MethylationEPIC array, and EM-Seq for DNA methylation detection.

Computational biology and chemistry·2026
See all related articles

Related Experiment Video

Updated: Jan 13, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.5K

A multi-layer hypergraph framework for drug-drug interaction prediction based on transformer and hypergraph

Lu Shen1, Feng Hu1, Libing Bai1

  • 1Computer College of Qinghai Normal University, Xining, Qinghai 810008, China; The State Key Laboratory of Tibetan Intelligence, Xining, Qinghai 810008, China.

Computational Biology and Chemistry
|January 11, 2026
PubMed
Summary
This summary is machine-generated.

Predicting drug-drug interactions (DDIs) is vital for safe medication. A new Multi-Layer Hypergraph framework using Transformer and Hypergraph Convolution (MLHTHC) improves DDI prediction accuracy by capturing complex relationships.

Keywords:
Drug-Drug InteractionHypergraph ConvolutionMulti-Layer HypergraphTransformer

More Related Videos

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.5K

Related Experiment Videos

Last Updated: Jan 13, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.5K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.5K

Area of Science:

  • Pharmacology and Cheminformatics
  • Artificial Intelligence in Drug Discovery

Background:

  • Drug-drug interactions (DDIs) pose significant challenges in drug research and clinical practice.
  • Existing network models struggle to capture complex, multi-element synergistic drug interactions.
  • Accurate DDI prediction is crucial for enhancing treatment safety and optimizing medication regimens.

Purpose of the Study:

  • To develop an advanced framework for predicting drug-drug interactions (DDIs) that overcomes limitations of conventional models.
  • To effectively represent and analyze multi-element synergistic interactions among drugs.
  • To improve the accuracy and reliability of DDI prediction.

Main Methods:

  • Proposed a Multi-Layer Hypergraph framework for drug interaction prediction using Transformer and Hypergraph Convolution (MLHTHC).
  • Constructed a multi-layer drug similarity hypergraph using chemical structure, ATC code, drug category, and target information.
  • Employed spectral Hamming similarity for layer weight determination, hypergraph convolutional networks for node embedding, Transformer for feature fusion, and MLP for DDI prediction.

Main Results:

  • The MLHTHC model demonstrated superior performance compared to existing methods like DPSP and DANN.
  • The integration of Transformer and hypergraph convolution significantly enhanced prediction accuracy for drug-drug interactions.
  • The framework effectively captures complex, multi-element synergistic drug relationships.

Conclusions:

  • The proposed MLHTHC framework offers a powerful and effective tool for predicting drug-drug interactions.
  • This approach advances the field of computational pharmacology by improving DDI prediction capabilities.
  • Accurate DDI prediction using MLHTHC can lead to safer and more effective pharmacotherapy.